Home » Topics » BioWorld Science

BioWorld Science
RSS

Infergen NDA filed in U.S.

April 26, 1996

Sanwa's SKK-47029 for disorders of gastric emptying

April 26, 1996

Amgen initiates phase I trials with KGF

April 26, 1996

Byk Gulden claims agents for H. pylori control

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

5alpha-Reductase inhibitors for BPH disclosed by Lilly

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Genelabs develops two oral antithrombotics

April 26, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...